OncoSTING Overview
- Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$256K
- Investors
-
4
OncoSTING General Information
Description
Developer of a biopharma therapy designed to cure bladder cancer. The company's therapy work by combining the potency of standard BCG immunotherapy with long-lived delivery of potent STING agonists, enabling doctors to cure bladder cancer with reduced adverse events associated with traditional BCG.
Contact Information
Website
www.oncosting.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 17 South Chester Street
- Baltimore, MD 21231
- United States
OncoSTING Timeline
OncoSTING Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Jun-2022 | $256K | 00000 | Completed | Generating Revenue | |
| 4. Grant | 08-Jul-2019 | 00000 | 00000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 02-Jul-2019 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 28-Jun-2019 | Completed | Generating Revenue | |||
| 1. Grant | 23-Feb-2018 | Completed | Generating Revenue |
OncoSTING Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Todd Wallach | Chief Business Officer | ||
| Trinity Bivalacqua Ph.D | Co-Founder | ||
| William Bishai Ph.D | Co-Founder |
OncoSTING Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ambaw Bellete | OncoSTING | Chairman | 000 0000 |
OncoSTING Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| National Science Foundation | Government | 000 0000 | 000000 0 | ||
| Johns Hopkins University Endowment | Limited Partner | 000 0000 | 000000 0 | ||
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 |